Europe Hip Replacement Market Report by Product, End-User, Countries and Companies Analysis 2026-2034

Europe Hip Replacement Market Size and Forecast 2026-2034

Europe Hip Replacement Market is expected to reach US$ 2.79 Billion by 2034 from US$ 1.95 Billion in 2025, with a CAGR of 4.04% from 2026 to 2034. The Europe hip replacement market is driven by the increasing prevalence of osteoarthritis and other degenerative joint disorders, growing elderly populations, rising demand for mobility-restoring procedures, and continuous advancements in implant materials, robotic-assisted surgery, and minimally invasive orthopedic technologies.

Europe Hip Replacement Industry Overview

Hip replacement is a surgical procedure that involves replacing a damaged or diseased hip joint with an artificial implant to restore mobility, reduce pain, and improve quality of life. The procedure is commonly performed in patients suffering from osteoarthritis, rheumatoid arthritis, hip fractures, avascular necrosis, and other degenerative joint conditions. Modern hip implants are typically composed of metal, ceramic, or polyethylene components designed to mimic the natural movement of the hip joint. Technological advancements such as robotic-assisted surgery, navigation systems, and improved implant materials have enhanced surgical precision, implant longevity, and patient outcomes, making hip replacement one of the most successful orthopedic procedures.

The European hip replacement market is experiencing steady growth due to the rising burden of age-related musculoskeletal disorders and increasing demand for effective mobility restoration treatments. Growing life expectancy across European countries has expanded the patient pool requiring hip arthroplasty procedures. Additionally, advancements in implant design, biomaterials, robotic-assisted surgery, and digital planning technologies are improving clinical outcomes and encouraging procedure adoption. Increasing healthcare expenditure and broader access to orthopedic care further support market expansion. The trend toward minimally invasive surgical techniques and personalized implants is also contributing to demand, while continuous innovation by orthopedic device manufacturers strengthens the overall growth trajectory of the European market.

Recent Developments in Europe Hip Replacement Market

• September 2024: Stryker launched the Gamma4 Hip Fracture Nailing System across Europe, expanding its trauma portfolio with an advanced intramedullary fixation platform designed to support the treatment of hip and femur fractures while improving surgical efficiency and procedural versatility.

Growth Drivers for the Europe Hip Replacement Market

Increasing Adoption of Advanced Hip Implant Technologies

Technological advancements in hip implant design and materials are playing a crucial role in driving the Europe hip replacement market. Manufacturers are increasingly focusing on developing implants with enhanced durability, improved wear resistance, and better anatomical compatibility to optimize long-term patient outcomes. Innovations in ceramic bearings, advanced polyethylene materials, and bone-preserving implant designs are helping reduce complications and revision rates while improving joint function and mobility. These advancements are encouraging wider adoption of hip replacement procedures among both elderly and active patient populations.

A notable example of this trend occurred in July 2025, when MatOrtho received CE Mark approval for its ReCerf Hip Resurfacing Arthroplasty, a ceramic-on-ceramic hip resurfacing system designed to preserve more bone while offering an alternative to conventional total hip replacement procedures. The introduction of such next-generation implant technologies reflects the industry's focus on improving implant longevity, patient satisfaction, and overall surgical outcomes, thereby supporting market growth across Europe.

Expansion of Robotic-Assisted and Digital Surgical Platforms

The growing adoption of robotic-assisted surgery and digital orthopedic technologies is significantly contributing to the growth of the European hip replacement market. Healthcare providers are increasingly utilizing advanced planning software, navigation systems, and robotic platforms to improve surgical precision and implant positioning. These technologies enable personalized treatment planning based on patient-specific anatomy, helping surgeons achieve more accurate outcomes and reduce the risk of complications. As hospitals focus on improving procedural efficiency and patient recovery, demand for digitally enabled orthopedic solutions continues to increase.

Reflecting this trend, Smith+Nephew launched the CATALYSTEM(TM) Primary Hip System in July 2024, a platform designed to support modern hip arthroplasty procedures and integrate with advanced surgical technologies. The system aims to improve surgical workflow and implant performance while addressing evolving clinical needs. Such innovations are strengthening confidence in hip replacement procedures and encouraging broader adoption of advanced orthopedic solutions across European healthcare facilities.

Rising Demand for Personalized Hip Replacement Procedures

Personalized medicine is becoming an increasingly important factor in the European hip replacement market as healthcare providers seek to tailor surgical procedures to individual patient needs. Advances in imaging, digital planning, and data-driven surgical technologies are enabling more customized treatment approaches, leading to improved implant alignment, enhanced mobility, and better long-term outcomes. Patients are also becoming more informed about treatment options and are increasingly seeking procedures that offer faster recovery, greater functionality, and improved quality of life. This trend is encouraging manufacturers to develop solutions that support personalized surgical planning and execution.

Supporting this shift, Corin introduced ApolloHipX in June 2025, an advanced total hip arthroplasty solution that combines three-dimensional preoperative planning with real-time intraoperative validation. The platform is designed to help surgeons make more informed decisions throughout the procedure and optimize implant placement based on patient-specific anatomy. Such innovations are accelerating the adoption of personalized hip replacement procedures and contributing to market expansion across Europe.

Challenges in the Europe Hip Replacement Market

High Procedure and Implant Costs

Despite favorable clinical outcomes, hip replacement procedures remain associated with substantial costs related to implants, surgical equipment, hospital stays, rehabilitation, and postoperative care. Advanced implant technologies, robotic-assisted systems, and navigation platforms often require significant capital investments from healthcare providers. Cost pressures are particularly evident in publicly funded healthcare systems where budget constraints can limit technology adoption and influence procurement decisions. Reimbursement variations across European countries may also affect patient access to advanced procedures and premium implants. Additionally, increasing healthcare expenditure associated with an aging population places additional financial pressure on healthcare systems. These factors can slow the adoption of newer technologies and create challenges for manufacturers seeking widespread market penetration across diverse European healthcare environments.

Risk of Revision Surgeries and Postoperative Complications

Although hip replacement surgery is considered highly successful, complications such as implant loosening, infection, dislocation, wear, and periprosthetic fractures continue to present challenges for healthcare providers and patients. Revision procedures are generally more complex, costly, and technically demanding than primary surgeries. As younger and more active patients increasingly undergo hip replacement procedures, expectations regarding implant longevity continue to rise. Healthcare providers must therefore balance long-term implant performance with patient-specific factors such as activity levels and bone quality. Regulatory scrutiny and the need for extensive clinical evidence further increase development requirements for new implant systems. These challenges encourage manufacturers to continuously invest in innovation, quality improvement, and long-term clinical validation.

Germany Hip Replacement Market

Germany is one of the leading knee replacement markets in Europe, supported by a large ageing population and a well-established orthopedic care infrastructure. People aged 65 years and above accounted for approximately 22.7% of the population in 2025, creating a substantial patient pool vulnerable to osteoarthritis and other degenerative joint disorders. Additionally, Germany is among the countries with the strongest growth in joint replacement procedures, recording a hip replacement rate of approximately 351 procedures per 100,000 population, reflecting the country's high utilization of orthopedic surgical services. Strong reimbursement coverage, advanced hospital networks, and increasing adoption of innovative implant technologies further support market growth. Rising life expectancy and growing demand for mobility among older adults are expected to continue driving knee replacement procedure volumes across the country.

France Hip Replacement Market

France represents a mature and steadily expanding knee replacement market, driven primarily by demographic ageing and increasing prevalence of osteoarthritis. Individuals aged 65 years and above represented approximately 21.9% of the French population in 2025, highlighting a significant target population for knee arthroplasty procedures. As age is one of the most important risk factors for knee degeneration, the growing elderly population continues to increase demand for joint replacement surgeries. France benefits from a comprehensive healthcare system, widespread access to orthopedic specialists, and favorable reimbursement policies that support procedure uptake. In addition, advancements in implant design, surgical techniques, and postoperative rehabilitation are improving patient outcomes and encouraging treatment adoption. These factors collectively position France as an important contributor to the Western European knee replacement market.

Italy Hip Replacement Market

Italy is an important knee replacement market in Southern Europe, supported by increasing demand for orthopedic interventions and a growing burden of age-related joint disorders. The country recorded approximately 222 hip replacement procedures per 100,000 population in 2023, demonstrating strong utilization of joint replacement surgeries and a well-developed orthopedic care ecosystem. Rising life expectancy and the increasing prevalence of osteoarthritis continue to create sustained demand for knee arthroplasty procedures. The market is further supported by expanding access to specialized orthopedic centers, technological advancements in implant materials, and improved surgical techniques that enhance long-term outcomes. Growing awareness regarding mobility preservation and quality-of-life improvement among older adults is also contributing to procedure growth. These factors are expected to support continued expansion of Italy's knee replacement market over the coming years.

Spain Hip Replacement Market

Spain's knee replacement market is experiencing steady growth, supported by demographic trends and increasing demand for treatment of degenerative joint diseases. People aged 65 years and above accounted for approximately 20.7% of the population in 2025, creating a large patient population at elevated risk of osteoarthritis and knee-related disabilities. As the elderly population continues to expand, demand for total and partial knee replacement procedures is expected to increase correspondingly. Spain's public healthcare system, growing availability of orthopedic specialists, and ongoing improvements in surgical technologies are facilitating greater access to joint replacement treatments. Additionally, increasing patient expectations regarding mobility, independence, and quality of life are encouraging earlier intervention for severe knee conditions. These factors collectively support the long-term growth outlook of the Spanish knee replacement market.

Europe Total Hip Replacement Market

The total hip replacement segment represents a major portion of the Europe hip replacement market due to its widespread use in treating advanced osteoarthritis, rheumatoid arthritis, avascular necrosis, and severe hip injuries. The procedure involves replacing both the femoral head and acetabular socket with prosthetic components, providing significant pain relief and restoring joint function. Market growth is supported by the increasing prevalence of degenerative joint disorders, growing elderly populations, and rising demand for mobility-restoring treatments. Continuous advancements in implant materials, surgical techniques, and digital planning technologies are improving clinical outcomes and patient satisfaction. Additionally, increasing adoption of minimally invasive procedures and personalized implant solutions is strengthening demand for total hip replacement systems across hospitals and orthopedic centers throughout Europe.

Europe Orthopedic Clinics Market

Orthopedic clinics play an increasingly important role in the Europe hip replacement market by providing specialized musculoskeletal care, surgical consultations, and rehabilitation services. These facilities are becoming key centers for patient evaluation, treatment planning, postoperative monitoring, and long-term recovery management. Growing demand for specialized orthopedic services, coupled with efforts to improve patient outcomes and reduce healthcare system burdens, is driving the expansion of orthopedic clinics across Europe. Many clinics are adopting advanced diagnostic tools, digital surgical planning technologies, and enhanced recovery protocols to support hip replacement procedures. The shift toward patient-centered care and streamlined treatment pathways is further increasing the importance of orthopedic clinics within the hip replacement ecosystem. Their specialized expertise continues to support the growing demand for hip arthroplasty services across the region.

Europe Hip Replacement Market Segmentation:

Product

• Total HIP Replacement
• Partial HIP Replacement
• Revision HIP Replacement

End User

• Hospitals & Surgery Centers
• Orthopaedic clinics
• Others

Countries

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Russia
• Poland
• Greece
• Norway
• Romania
• Portugal
• Rest of Europe

All companies have been covered from 4 viewpoints:

• Overview
• Key Persons
• Recent Development
• Financial Insights

Company Analysis

• Smith & Nephew PLC
• Johnson & Johnson
• Integra lifesciences Corporation
• MicroPort Scientific Corp
• Zimmer Biomet Holdings Inc
• Stryker Corporation
• B. Braun Melsungen AG
• Globus Medical Inc.